The Business Research Company’s Immunodiagnostics Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, August 11, 2026 /EINPresswire.com/ — “The immunodiagnostics sector has witnessed substantial growth recently, driven by advancements in healthcare and diagnostic technologies. As the demand for precise and timely disease detection rises, this market is set to continue expanding in the coming years. Let’s explore the current market size, growth drivers, regional dynamics, and emerging trends shaping the future of immunodiagnostics.
Immunodiagnostics Market Size and Its Growth Outlook
The immunodiagnostics market has shown strong development over recent years, with its size projected to increase from $24.32 billion in 2025 to $26.16 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.5%. The growth observed during the past period is largely due to the increasing incidence of infectious and chronic diseases, expansion of clinical laboratory networks, a rising demand for early disease diagnosis, greater use of antibody-based diagnostic methods, and the availability of standardized immunoassay technologies.
Download a free sample of the immunodiagnostics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Looking forward, the market is expected to expand significantly, reaching $35.76 billion by 2030, supported by a CAGR of 8.1%. This forecasted growth is attributed to several factors such as the increasing adoption of personalized diagnostics, growing investments in automated laboratory systems, the expansion of point-of-care immunodiagnostics, enhanced use of AI for interpreting results, and a stronger focus on preventive healthcare testing. Notable trends anticipated in this period include the rising utilization of automated immunoassay analyzers, growing demand for high-sensitivity diagnostic tests, wider use of rapid immunodiagnostic kits, development of multiplex testing capabilities, and improved integration of laboratory data management systems.
Understanding Immunodiagnostics and Its Diagnostic Role
Immunodiagnostics is a diagnostic approach primarily based on the antigen-antibody interaction used for detecting serum insulin and other biomarkers. These tests are crucial for identifying antibodies and parasite antigens, playing an important role in diagnosing various diseases accurately and efficiently.
View the full immunodiagnostics market report:
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
The Growing Impact of Chronic Diseases on Immunodiagnostics Demand
One of the major forces driving the immunodiagnostics market is the rising prevalence of chronic diseases globally. Chronic conditions such as diabetes, cardiovascular disease, and arthritis are long-term illnesses that often develop slowly and require continuous medical care alongside lifestyle adjustments to manage symptoms and prevent complications. The increase in these diseases is largely linked to unhealthy habits including poor nutrition, lack of physical activity, and smoking, all of which contribute to elevated risks for obesity, heart disease, and diabetes.
Immunodiagnostic tools help in the early detection and ongoing monitoring of chronic illnesses by identifying specific biomarkers or immune responses associated with these conditions. This improves patient care by supporting timely diagnosis and treatment decisions. For example, in June 2024, the UK’s National Health Service reported that 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or prediabetes in 2023. This figure marks an 18% rise from 3,065,825 cases in 2022, highlighting the growing burden of chronic conditions and the subsequent market demand for immunodiagnostic solutions.
Regional Leadership and Market Coverage in Immunodiagnostics
In 2025, North America held the largest share of the global immunodiagnostics market, establishing itself as a major regional leader. The market analysis encompasses key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market trends and growth opportunities.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
